Photodynamic therapy for localized infections—State of the art

Photodiagnosis and Photodynamic Therapy - Tập 6 - Trang 170-188 - 2009
Tianhong Dai1,2, Ying-Ying Huang1,2,3, Michael R. Hamblin1,2,4
1Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, United States
2Department of Dermatology, Harvard Medical School, Boston, MA, United States
3Aesthetic and Plastic Center of Guangxi Medical University, Nanning, PR China
4Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, United States

Tài liệu tham khảo

Bell, 2003, Antibiotic resistance: is the end of an era near?, Neonatal Netw, 22, 47, 10.1891/0730-0832.22.6.47 Poole, 1993, Are we facing the end of the antibiotic era?, Ear Nose Throat J, 72, 433, 10.1177/014556139307200614 Harrison, 1998, The beginning of the end of the antibiotic era? Part II. Proposed solutions to antibiotic abuse, Quintessence Int, 29, 223 Mroz, 2008 Ochsner, 1997, Photophysical and photobiological processes in the photodynamic therapy of tumours, J Photochem Photobiol B, 39, 1, 10.1016/S1011-1344(96)07428-3 O’Riordan, 2006, Photoinactivation of Mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection, Antimicrob Agents Chemother, 50, 1828, 10.1128/AAC.50.5.1828-1834.2006 Wilson, 2004, Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infections, Photochem Photobiol Sci, 3, 412, 10.1039/b211266c Bergmans, 2008, Effect of photo-activated disinfection on endodontic pathogens ex vivo, Int Endod J, 41, 227, 10.1111/j.1365-2591.2007.01344.x Hamblin, 2004, Photodynamic therapy: a new antimicrobial approach to infectious disease?, Photochem Photobiol Sci, 3, 436, 10.1039/b311900a Maisch, 2009, A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment, Mini Rev Med Chem, 9, 947, 10.2174/138955709788681582 Tang, 2007, A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens, J Infect Chemother, 13, 87, 10.1007/s10156-006-0501-8 Lauro, 2002, Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates, Photochem Photobiol Sci, 1, 468, 10.1039/b200977c Moan, 2003, An outline of the hundred-year history of PDT, Anticancer Res, 23, 3591 Nitzan, 1992, Inactivation of gram-negative bacteria by photosensitized porphyrins, Photochem Photobiol, 55, 89, 10.1111/j.1751-1097.1992.tb04213.x Minnock, 2000, Mechanism of uptake of a cationic water-soluble pyridinium zinc phthalocyanine across the outer membrane of Escherichia coli, Antimicrob Agents Chemother, 44, 522, 10.1128/AAC.44.3.522-527.2000 Bertoloni, 1990, Photosensitizing activity of water- and lipid-soluble phthalocyanines on Escherichia coli, FEMS Microbiol Lett, 59, 149, 10.1111/j.1574-6968.1990.tb03814.x Lazzeri, 2004, Photodynamic studies and photoinactivation of Escherichia coli using meso-substituted cationic porphyrin derivatives with asymmetric charge distribution, Photochem Photobiol, 80, 286, 10.1562/2004-03-08-RA-105.1 Segalla, 2002, Photophysical, photochemical and antibacterial photosensitizing properties of a novel octacationic Zn(II)-phthalocyanine, Photochem Photobiol Sci, 1, 641, 10.1039/b202031a Minnock, 1996, Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria, J Photochem Photobiol B, 32, 159, 10.1016/1011-1344(95)07148-2 Usacheva, 2001, Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms, Lasers Surg Med, 29, 165, 10.1002/lsm.1105 Wainwright, 2002, Methylene Blue—a therapeutic dye for all seasons?, J Chemother, 14, 431, 10.1179/joc.2002.14.5.431 Wainwright, 1998, Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus, FEMS Microbiol Lett, 160, 177, 10.1111/j.1574-6968.1998.tb12908.x Maisch, 2005, Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells, Antimicrob Agents Chemother, 49, 1542, 10.1128/AAC.49.4.1542-1552.2005 Kussovski, 2009, Photodynamic inactivation of Aeromonas hydrophila by cationic phthalocyanines with different hydrophobicity, FEMS Microbiol Lett, 294, 133, 10.1111/j.1574-6968.2009.01555.x Tegos, 2005, Cationic fullerenes are effective and selective antimicrobial photosensitizers, Chem Biol, 12, 1127, 10.1016/j.chembiol.2005.08.014 Hamblin, 2002, Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria, J Antimicrob Chemother, 49, 941, 10.1093/jac/dkf053 Soukos, 1998, Targeted antimicrobial photochemotherapy, Antimicrob Agents Chemother, 42, 2595, 10.1128/AAC.42.10.2595 Tegos, 2006, Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation, Antimicrob Agents Chemother, 50, 1402, 10.1128/AAC.50.4.1402-1410.2006 George, 2009, Uptake pathways of anionic and cationic photosensitizers into bacteria, Photochem Photobiol Sci, 8, 788, 10.1039/b809624d Demidova, 2004, Photodynamic therapy targeted to pathogens, Int J Immunopathol Pharmacol, 17, 245, 10.1177/039463200401700304 Nitzan, 1998, Eradication of Acinetobacter baumannii by photosensitized agents in vitro, J Photochem Photobiol B, 42, 211, 10.1016/S1011-1344(98)00073-6 Wilson, 1995, Lethal photosensitisation of Staphylococcus aureus in vitro: effect of growth phase, serum, and pre-irradiation time, Lasers Surg Med, 16, 272, 10.1002/lsm.1900160309 Lambrechts, 2005, Effect of albumin on the photodynamic inactivation of microorganisms by a cationic porphyrin, J Photochem Photobiol B, 79, 51, 10.1016/j.jphotobiol.2004.11.020 Street, 2009, Antimicrobial photodynamic therapy for the decolonization of methicillin-resistant Staphylococcus aureus from the anterior nares, Proc SPIE, 7380, 10.1117/12.828279 Mohr, 1997, Virus inactivation of blood products by phenothiazine dyes and light, Photochem Photobiol, 65, 441, 10.1111/j.1751-1097.1997.tb08586.x Mohr, 2004, West Nile virus in plasma is highly sensitive to methylene blue-light treatment, Transfusion, 44, 886, 10.1111/j.1537-2995.2004.03424.x Mohr, 2003, Inactivation of pathogens in platelet concentrates by using a two-step procedure, Vox Sang, 84, 96, 10.1046/j.1423-0410.2003.00270.x Ben-Hur, 1995, The effect of irradiance on virus sterilization and photodynamic damage in red blood cells sensitized by phthalocyanines, Photochem Photobiol, 61, 190, 10.1111/j.1751-1097.1995.tb03959.x Ben-Hur, 1997, Photodynamic treatment of red blood cell concentrates for virus inactivation enhances red blood cell aggregation: protection with antioxidants, Photochem Photobiol, 66, 509, 10.1111/j.1751-1097.1997.tb03181.x Maisch, 2007, Determination of the antibacterial efficacy of a new porphyrin-based photosensitizer against MRSA ex vivo, Photochem Photobiol Sci, 6, 545, 10.1039/b614770d Smijs, 2007, A novel ex vivo skin model to study the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment in different growth phases, J Antimicrob Chemother, 59, 433, 10.1093/jac/dkl490 Rocas, 2004, Association of Enterococcus faecalis with different forms of periradicular diseases, J Endod, 30, 315, 10.1097/00004770-200405000-00004 Millson, 1996, Ex vivo treatment of gastric Helicobacter infection by photodynamic therapy, J Photochem Photobiol B, 32, 59, 10.1016/1011-1344(95)07190-3 Wood, 2009, Insights on Escherichia coli biofilm formation and inhibition from whole-transcriptome profiling, Environ Microbiol, 11, 1, 10.1111/j.1462-2920.2008.01768.x Lewis, 2008, Multidrug tolerance of biofilms and persister cells, Curr Top Microbiol Immunol, 322, 107, 10.1007/978-3-540-75418-3_6 Jain, 2007, Biofilms—a microbial life perspective: a critical review, Crit Rev Ther Drug Carrier Syst, 24, 393, 10.1615/CritRevTherDrugCarrierSyst.v24.i5.10 Demidova, 2005, Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria, J Photochem Photobiol B, 81, 15, 10.1016/j.jphotobiol.2005.05.007 Rocchetta, 2001, Validation of a noninvasive, real-time imaging technology using bioluminescent escherichia coli in the neutropenic mouse thigh model of infection, Antimicrob Agents Chemother, 45, 129, 10.1128/AAC.45.1.129-137.2001 Francis, 2000, Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct, Infect Immun, 68, 3594, 10.1128/IAI.68.6.3594-3600.2000 Francis, 2001, Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon, Infect Immun, 69, 3350, 10.1128/IAI.69.5.3350-3358.2001 Hamblin, 2002, Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging, Photochem Photobiol, 75, 51, 10.1562/0031-8655(2002)075<0051:RCOWIB>2.0.CO;2 Hamblin, 2003, Optical monitoring and treatment of potentially lethal wound infections in vivo, J Infect Dis, 187, 1717, 10.1086/375244 Wong, 2005, Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus, Antimicrob Agents Chemother, 49, 895, 10.1128/AAC.49.3.895-902.2005 Zolfaghari, 2009, In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent, BMC Microbiol, 9, 27, 10.1186/1471-2180-9-27 Orenstein, 1997, The use of porphyrins for eradication of Staphylococcus aureus in burn wound infections, FEMS Immunol Med Microbiol, 19, 307, 10.1016/S0928-8244(97)00097-7 Lambrechts, 2005, Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice, Photochem Photobiol Sci, 4, 503, 10.1039/b502125a Dai, 2009, Photodynamic therapy for Acinetobacter baumannii burn infections in mice, Antimicrob Agents Chemother, 10.1128/AAC.00027-09 Berthiaume, 1994, Antibody-targeted photolysis of bacteria in vivo, Biotechnology (NY), 12, 703, 10.1038/nbt0794-703 Gad, 2004, Targeted photodynamic therapy of established soft-tissue infections in mice, Photochem Photobiol Sci, 3, 451, 10.1039/b311901g Shibli, 2003, Treatment of ligature-induced peri-implantitis by lethal photosensitization and guided bone regeneration: a preliminary histologic study in dogs, J Periodontol, 74, 338, 10.1902/jop.2003.74.3.338 Komerik, 2003, In vivo killing of Porphyromonas gingivalis by toluidine blue-mediated photosensitization in an animal model, Antimicrob Agents Chemother, 47, 932, 10.1128/AAC.47.3.932-940.2003 Fernandes, 2009, Treatment of experimental periodontal disease by photodynamic therapy in immunosuppressed rats, J Clin Periodontol, 36, 219, 10.1111/j.1600-051X.2008.01355.x de Almeida, 2008, Treatment of experimental periodontal disease by photodynamic therapy in rats with diabetes, J Periodontol, 79, 2156, 10.1902/jop.2008.080103 de Almeida, 2007, Influence of photodynamic therapy on the development of ligature-induced periodontitis in rats, J Periodontol, 78, 566, 10.1902/jop.2007.060214 Sigusch, 2005, Efficacy of photodynamic therapy on inflammatory signs and two selected periodontopathogenic species in a beagle dog model, J Periodontol, 76, 1100, 10.1902/jop.2005.76.7.1100 Teichert, 2002, Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 93, 155, 10.1067/moe.2002.120051 Lin, 2009, Toluidine blue-mediated photodynamic therapy of oral wound infections in rats, Lasers Med Sci Akilov, 2007, Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation, Photochem Photobiol Sci, 6, 1067, 10.1039/b703521g Akilov, 2007, Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells, Exp Dermatol, 16, 651, 10.1111/j.1600-0625.2007.00578.x Akilov, 2009, Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis, Lasers Surg Med, 41, 358, 10.1002/lsm.20775 O’Riordan, 2007, Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection, Photochem Photobiol Sci, 6, 1117, 10.1039/b707962a Jung, 2009, In vitro and in vivo photodynamic therapy of otitis media in gerbils, Laryngoscope, 10.1002/lary.20568 Bisland, 2006, Pre-clinical in vitro and in vivo studies to examine the potential use of photodynamic therapy in the treatment of osteomyelitis, Photochem Photobiol Sci, 5, 31, 10.1039/B507082A Smetana, 1997, Treatment of viral infections with 5-aminolevulinic acid and light, Lasers Surg Med, 21, 351, 10.1002/(SICI)1096-9101(1997)21:4<351::AID-LSM6>3.0.CO;2-P Moore, 1972, Photodynamic treatment of herpes keratitis, Infect Immun, 5, 169, 10.1128/IAI.5.2.169-171.1972 Lombard, 1985, The treatment of neurosurgical infections by lasers and porphyrins, 363 Tolstykh, 2001, Experimental study of photodynamic effect on bacterial wound microflora, Zh Mikrobiol Epidemiol Immunobiol, 85 Stranadko, 2000, Photodynamic therapy in suppurative diseases of soft tissue, Khirurgiia (Mosk), 67 Brown, 2009, Clinical developments in antimicrobial PDT Gold, 2007, Acne and PDT: new techniques with lasers and light sources, Lasers Med Sci, 22, 67, 10.1007/s10103-006-0420-z Houk, 2007, Masers to magic bullets: an updated history of lasers in dermatology, Clin Dermatol, 25, 434, 10.1016/j.clindermatol.2007.05.004 Johnsson, 1987, Fluorescence from pilosebaceous follicles, Arch Dermatol Res, 279, 190, 10.1007/BF00413256 Meffert, 1990, Therapy of acne with visible light. Decreased irradiation time by using a blue-light high-energy lamp, Dermatol Monatsschr, 176, 597 Ashkenazi, 2003, Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light, FEMS Immunol Med Microbiol, 35, 17, 10.1111/j.1574-695X.2003.tb00644.x Ramstad, 2006, The temperature dependence of porphyrin production in Propionibacterium acnes after incubation with 5-aminolevulinic acid (ALA) and its methyl ester (m-ALA), Photochem Photobiol Sci, 5, 66, 10.1039/B512837D Charakida, 2004, Phototherapy in the treatment of acne vulgaris: what is its role?, Am J Clin Dermatol, 5, 211, 10.2165/00128071-200405040-00001 Hongcharu, 2000, Topical ALA-photodynamic therapy for the treatment of acne vulgaris, J Invest Dermatol, 115, 183, 10.1046/j.1523-1747.2000.00046.x Wiegell, 2006, Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial, Br J Dermatol, 154, 969, 10.1111/j.1365-2133.2005.07107.x Wiegell, 2006, Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate, J Am Acad Dermatol, 54, 647, 10.1016/j.jaad.2005.12.033 Tuchin, 2003, A pilot study of ICG laser therapy of acne vulgaris: photodynamic and photothermolysis treatment, Lasers Surg Med, 33, 296, 10.1002/lsm.10211 Ryou, 2009, Acne-photodynamic therapy with intra-lesional injection of 5-aminolevulinic acid, Photodermatol Photoimmunol Photomed, 25, 57, 10.1111/j.1600-0781.2009.00399.x Hong, 2005, Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris, Photodermatol Photoimmunol Photomed, 21, 322, 10.1111/j.1600-0781.2005.00181.x Gold, 2007, Photodynamic therapy with lasers and intense pulsed light, Facial Plast Surg Clin North Am, 15, 145, 10.1016/j.fsc.2007.01.003 Nestor, 2007, The use of photodynamic therapy for treatment of acne vulgaris, Dermatol Clin, 25, 47, 10.1016/j.det.2006.09.014 Taylor, 2009, The practicalities of photodynamic therapy in acne vulgaris, Br J Dermatol, 160, 1140, 10.1111/j.1365-2133.2009.09054.x Bryld, 2006, The bacterial flora of the skin surface following routine MAL-PDT, J Dermatolog Treat, 17, 222, 10.1080/09546630600830570 Ceilley, 2004, Advances in the topical treatment of acne and rosacea, J Drugs Dermatol, 3, S12 Darras-Vercambre, 2006, Photodynamic action of red light for treatment of erythrasma: preliminary results, Photodermatol Photoimmunol Photomed, 22, 153, 10.1111/j.1600-0781.2006.00211.x Yung, 2007, Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream, Clin Exp Dermatol, 32, 716, 10.1111/j.1365-2230.2007.02472.x Calzavara-Pinton, 2005, A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin, J Photochem Photobiol B, 78, 1, 10.1016/j.jphotobiol.2004.06.006 Donnelly, 2008, Antifungal photodynamic therapy, Microbiol Res, 163, 1, 10.1016/j.micres.2007.08.001 Donnelly, 2006, Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O, J Photochem Photobiol B Calzavara-Pinton, 2004, Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid, Photodermatol Photoimmunol Photomed, 20, 144, 10.1111/j.1600-0781.2004.00095.x Kim, 2007, Successful treatment of pityriasis versicolor with 5-aminolevulinic acid photodynamic therapy, Arch Dermatol, 143, 1218, 10.1001/archderm.143.9.1218 Sotiriou, 2008, 5-Aminolevulinic acid-photodynamic treatment for dermatophytic tinea pedis of interdigital type: a small clinical study, J Eur Acad Dermatol Venereol Moravvej, 2007, Association of rosacea with demodicosis, Arch Iran Med, 10, 199 Skrlin, 1991, Demodicosis and rosacea, Lancet, 337, 734, 10.1016/0140-6736(91)90318-J Yamasaki, 2007, Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea, Nat Med, 13, 975, 10.1038/nm1616 Bryld, 2007, Photodynamic therapy in a series of rosacea patients, J Eur Acad Dermatol Venereol, 21, 1199 Katz, 2006, Photodynamic therapy for the treatment of erythema, papules, pustules, and severe flushing consistent with rosacea, J Drugs Dermatol, 5, 6 Derkay, 2008, Recurrent respiratory papillomatosis: a review, Laryngoscope, 118, 1236, 10.1097/MLG.0b013e31816a7135 Shikowitz, 1998, Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results, Laryngoscope, 108, 962, 10.1097/00005537-199807000-00002 Abramson, 1992, Clinical effects of photodynamic therapy on recurrent laryngeal papillomas, Arch Otolaryngol Head Neck Surg, 118, 25, 10.1001/archotol.1992.01880010029011 Bujia, 1993, Photodynamic therapy with derivatives from hemotoporphyrines for recurrent laryngeal papillomatosis of the children. Early results, Otorrinolaringol Ibero Am, 20, 251 Ichimura, 2003, Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia, Int J Clin Oncol, 8, 322, 10.1007/s10147-003-0354-4 Abdel-Hady, 2001, Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy, Cancer Res, 61, 192 Ross, 1997, Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment, Br J Dermatol, 137, 736, 10.1111/j.1365-2133.1997.tb01110.x Fehr, 1996, Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid, Am J Obstet Gynecol, 174, 951, 10.1016/S0002-9378(96)70332-0 Chen, 2007, Comparative study of photodynamic therapy vs CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial, Br J Dermatol, 156, 516, 10.1111/j.1365-2133.2006.07648.x Szeimies, 2009, Adjuvant photodynamic therapy does not prevent recurrence of condylomata acuminata after carbon dioxide laser ablation-A phase III, prospective, randomized, bicentric, double-blind study, Dermatol Surg, 35, 757, 10.1111/j.1524-4725.2009.01125.x Herzinger, 2006, Photodynamic therapy of genital condylomata in men, Clin Exp Dermatol, 31, 51, 10.1111/j.1365-2230.2005.01935.x Wang, 2004, Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata, Br J Dermatol, 151, 880, 10.1111/j.1365-2133.2004.06189.x Schroeter, 2005, Photodynamic therapy: new treatment for therapy-resistant plantar warts, Dermatol Surg, 31, 71, 10.1111/j.1524-4725.2005.31011 Stender, 1999, Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study, Clin Exp Dermatol, 24, 154, 10.1046/j.1365-2230.1999.00441.x Stender, 2000, Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial, Lancet, 355, 963, 10.1016/S0140-6736(00)90013-8 Stender, 2006, Pain induced by photodynamic therapy of warts, Photodermatol Photoimmunol Photomed, 22, 304, 10.1111/j.1600-0781.2006.00259.x Gold, 2004, The successful use of ALA-PDT in the treatment of recalcitrant molluscum contagiosum, J Drugs Dermatol, 3, 187 Scheinfeld, 2007, Treatment of molluscum contagiosum: a brief review and discussion of a case successfully treated with adapelene, Dermatol Online J, 13, 15, 10.5070/D387V1Z7HT Roome, 1975, Neutral red with photoinactivation in the treatment of herpes genitalis, Br J Vener Dis, 51, 130 Kaufman, 1973, Herpes genitalis treated by photodynamic inactivation of virus, Am J Obstet Gynecol, 117, 1144, 10.1016/0002-9378(73)90768-0 Bockstahler, 1975, A review of photodynamic therapy for herpes simplex: benefits and potential risks, N Y J Dent, 45, 148 Myers, 1975, Failure of neutral-red photodynamic inactivation in recurrent herpes simplex virus infections, N Engl J Med, 293, 945, 10.1056/NEJM197511062931901 Friedrich, 1976, Vulvar histology after neutral red photoinactivation of herpes simplex virus, Obstet Gynecol, 48, 564 Asilian, 2006, Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial, Clin Exp Dermatol, 10.1111/j.1365-2230.2006.02182.x Gardlo, 2003, Treatment of cutaneous leishmaniasis by photodynamic therapy, J Am Acad Dermatol, 48, 893, 10.1067/mjd.2003.218 Sohl, 2007, Photodynamic treatment of cutaneous leishmaniasis, J Dtsch Dermatol Ges, 5, 128, 10.1111/j.1610-0387.2007.06177.x Gonzalez, 2008, Interventions for Old World cutaneous leishmaniasis, Cochrane Database Syst Rev, CD005067 de Oliveira, 2009, Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: cytokine profile in gingival crevicular fluid, preliminary results, J Periodontol, 80, 98, 10.1902/jop.2009.070465 Chondros, 2008, Photodynamic therapy as adjunct to non-surgical periodontal treatment in patients on periodontal maintenance: a randomized controlled clinical trial, Lasers Med Sci Braun, 2008, Short-term clinical effects of adjunctive antimicrobial photodynamic therapy in periodontal treatment: a randomized clinical trial, J Clin Periodontol, 35, 877, 10.1111/j.1600-051X.2008.01303.x Christodoulides, 2008, Photodynamic therapy as an adjunct to non-surgical periodontal treatment: a randomized, controlled clinical trial, J Periodontol, 79, 1638, 10.1902/jop.2008.070652 Qin, 2008, Comparison of toluidine blue-mediated photodynamic therapy and conventional scaling treatment for periodontitis in rats, J Periodontal Res, 43, 162, 10.1111/j.1600-0765.2007.01007.x Garcez, 2008, Antimicrobial effects of photodynamic therapy on patients with necrotic pulps and periapical lesion, J Endod, 34, 138, 10.1016/j.joen.2007.10.020 Pinheiro, 2008, Photodynamic therapy in endodontic treatment of deciduous teeth, Lasers Med Sci Savarino, 2000, The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori, Aliment Pharmacol Ther, 14, 893, 10.1046/j.1365-2036.2000.00780.x Jodlowski, 2008, Emerging therapies for the treatment of Helicobacter pylori infections, Ann Pharmacother, 42, 1621, 10.1345/aph.1L234 Wilder-Smith, 2002, Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies, Lasers Surg Med, 31, 18, 10.1002/lsm.10066 Hamblin, 2005, Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light, Antimicrob Agents Chemother, 49, 2822, 10.1128/AAC.49.7.2822-2827.2005 Ganz, 2005, Helicobacter pylori in patients can be killed by visible light, Lasers Surg Med, 36, 260, 10.1002/lsm.20161 Lembo, 2009, Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial, Lasers Surg Med, 41, 337, 10.1002/lsm.20770 Castano, 2006, Photodynamic therapy and anti-tumour immunity, Nat Rev Cancer, 6, 535, 10.1038/nrc1894 Komerik, 2000, The effect of photodynamic action on two virulence factors of gram-negative bacteria, Photochem Photobiol, 72, 676, 10.1562/0031-8655(2000)072<0676:TEOPAO>2.0.CO;2